Cancer Susceptibility and Signaling Pathways in Low-Grade Brain Tumors |
Jewish General Hospital / Bárbara Rivera, PhD |
Young Investigator Grants |
2017 |
Quebec |
Role of Protocadherin-9 in Enabling Leukemia Cell Colonization of the CNS |
National Jewish Health / Jordan Jacobelli, PhD |
Innovation Grants |
2017 |
Colorado |
Characterization of Novel OTX2-semaphorin Gene Signaling Pathways Regulating the ‘Grow and Go’ Arms of Highly Aggressive Medulloblastomas |
University of Manitoba / Tamra Werbowetski-Ogilvie, PhD |
Innovation Grants |
2017 |
Manitoba |
Mechanisms of PAX3-FOXO1 and HES3 Cooperation in Rhabdomyosarcoma |
Nationwide Children’s Hospital / Genevieve Kendall, PhD |
'A' Award Grants |
2018 |
Ohio |
Single-cell Gene Expression and Cytosine Modification Profiling in Pediatric Central Nervous System Tumors |
Dartmouth College / Brock Christensen, PhD |
Single-cell Pediatric Cancer Atlas Grant |
2019 |
New Hampshire |
Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia |
Harvard University / Nick van Gastel, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1 |
Northwestern University (Illinois) / Zibo Zhao, PhD |
Young Investigator Grants |
2018 |
Illinois |
Molecular Landscape for Targeted Therapy in Retinoblastoma |
University of Miami / James Harbour, MD |
Innovation Grants |
2018 |
Florida |
Surviving Cancer CAMPetently: Evidence-based Care Delivered at Family Camp |
Nemours A.I. duPont Hospital for Children / Melissa Alderfer, PhD |
Psychosocial Family Impact Grant |
2018 |
Delaware |
Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival |
Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD |
Innovation Grants |
2017 |
Ohio |